{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:13:03Z","timestamp":1740136383236,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10072-021-05170-w","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:07:32Z","timestamp":1615853252000},"page":"5-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of fingolimod after switching from interferon \u03b2-1a in an adolescent with multiple sclerosis: case report"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-6948","authenticated-orcid":false,"given":"Annalisa","family":"Amidei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"5170_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S1474-4422(14)70093-6","volume":"13","author":"A Waldman","year":"2014","unstructured":"Waldman A, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M, Banwell B (2014) Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research. Lancet Neurol 13:936\u2013948. https:\/\/doi.org\/10.1016\/S1474-4422(14)70093-6","journal-title":"Lancet Neurol"},{"key":"5170_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/archneurol.2008.505","volume":"66","author":"MP Gorman","year":"2009","unstructured":"Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T (2009) Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 66:54\u201359. https:\/\/doi.org\/10.1001\/archneurol.2008.505","journal-title":"Arch Neurol"},{"key":"5170_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1352458517732843","volume":"25","author":"P Huppke","year":"2019","unstructured":"Huppke P, Huppke B, Ellenberger D, Rostasy K, Hummel H, Stark W et al (2019) Therapy of highly active pediatric multiple sclerosis. Mult Scler 25:72\u201380. https:\/\/doi.org\/10.1177\/1352458517732843","journal-title":"Mult Scler"},{"key":"5170_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/archneurol.2009.135","volume":"66","author":"E Waubant","year":"2009","unstructured":"Waubant E, Chabas D, Okuda DT, Glenn O, Mowry E, Henry RG et al (2009) Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol 66:967\u2013971. https:\/\/doi.org\/10.1001\/archneurol.2009.135","journal-title":"Arch Neurol"},{"key":"5170_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11940-016-0420-7","volume":"18","author":"M Simone","year":"2016","unstructured":"Simone M, Chitnis T (2016) Use of disease-modifying therapies in pediatric MS. Curr Treat Options Neurol 18:36. https:\/\/doi.org\/10.1007\/s11940-016-0420-7","journal-title":"Curr Treat Options Neurol"},{"key":"5170_CR6","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1212\/WNL.0000000000002823","volume":"87","author":"A Ghezzi","year":"2016","unstructured":"Ghezzi A, Amato MP, Makhani N, Shreiner T, Gartner J, Tenembaum S (2016) Pediatric multiple sclerosis: conventional first-line treatment and general management. Neurology 87:S97\u2013S102. https:\/\/doi.org\/10.1212\/WNL.0000000000002823","journal-title":"Neurology"},{"key":"5170_CR7","unstructured":"Novartis Europharm Ltd. Glienya (fingolimod) hard capsules [summary of product characteristics]. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/gilenya-epar-product-information_en.pdf. Accessed 17 Jan 2020"},{"key":"5170_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1056\/NEJMoa1800149","volume":"379","author":"T Chitnis","year":"2018","unstructured":"Chitnis T, Arnold DL, Banwell B, Bruck W, Ghezzi A, Giovannoni G et al (2018) Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis. N Engl J Med 379:1017\u20131027. https:\/\/doi.org\/10.1056\/NEJMoa1800149","journal-title":"N Engl J Med"},{"key":"5170_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pediatrneurol.2015.03.024","volume":"53","author":"YD Fragoso","year":"2015","unstructured":"Fragoso YD, Alves-Leon SV, Barreira AA, Callegaro D, Brito Ferreira ML, Finkelsztejn A et al (2015) Fingolimod prescribed for the treatment of multiple sclerosis in patients younger than age 18 years. Pediatr Neurol 53:166\u2013168. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.03.024","journal-title":"Pediatr Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05170-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T08:11:55Z","timestamp":1621325515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05170-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":9,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5170"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05170-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the local ethics committee of the Azienda Ospedaliero Universitaria Pisana in Italy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent to participate was obtained from legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent to publish was obtained from legal guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}